Risk of Production Shutdowns and Supply Delays Due to Infectious Diseases
First written in FY2020. 3 of 6 entries say "Mitigated", first in FY2021-Q1. Latest entry: FY2026.
The whole theme swung hardest in 2020: 103 of 175 companies on the "Worse" side.
- FY2026ReframedAnnual report
「If a major typhoon, major earthquake, river flooding, volcanic ashfall, infectious disease outbreak or other event occurs, employees and facilities of the Group may be affected, potentially interrupting business activities and delaying production and shipments.」
The risk of production stoppages due to infectious diseases was consolidated into the business interruption risk section, which also covers natural disasters and infectious diseases. - FY2023RestatedAnnual report
「Continuing from the previous fiscal year, the company established a task force for measures against COVID-19 and has implemented measures to prevent the spread of infection, including securing production and procurement systems, restricting business travel and instructing employees to work from home, in order to continue its business while giving top priority to human life.」
The company continued its infectious disease response headquarters, efforts to secure production and procurement systems, and business continuity measures involving travel restrictions and working from home. - FY2021MitigatedAnnual report
「From the second quarter onward, operations at the Philippines plant recovered steadily, and by the end of the consolidated fiscal year, utilization had reached levels above those before the suspension.」
The infectious disease caused a suspension of operations at the Philippines plant, but by the end of the fiscal year, utilization had recovered to levels above those before the suspension. - FY2021-Q2MitigatedAnnual report
「Operations were unavoidably suspended from mid-March to mid-May this year, but the Philippines plant has now recovered to pre-suspension operating levels.」
The infectious disease caused a suspension of operations at the Philippines plant, but operations were reported to have recovered to pre-suspension levels by the current quarter. - FY2021-Q1MitigatedAnnual report
「The impact of the COVID-19 pandemic, which continued from the end of the previous consolidated fiscal year, also persisted during the first quarter of the current consolidated fiscal year, and the timing of containment and the impact of the spread of infection remained uncertain. The Group had suspended operations at SANYO DENKI PHILIPPINES,INC. from mid-March 2020, at the end of the previous consolidated fiscal year, but resumed production activities on 18 May 2020 during the first quarter of the current consolidated fiscal year, and utilization rates were recovering toward pre-suspension levels.」
The impact of the infectious disease and the suspension of operations at the Philippines plant continued, but production activities resumed on 18 May 2020, and utilization rates were reported to be recovering toward pre-suspension levels. - FY2020MaterialisedAnnual report
「The global COVID-19 pandemic forced SANYO DENKI PHILIPPINES,INC. to suspend operations from mid-March to mid-May 2020, resulting in a partial decline in revenue at the end of the fiscal year.」
The infectious disease risk materialized as a suspension of operations at the Philippines production facility, leading to a partial decline in revenue at the end of the fiscal year and its deferral to the following fiscal year.